Status:
COMPLETED
EMG in COPD - Factor Analysis
Lead Sponsor:
Guy's and St Thomas' NHS Foundation Trust
Collaborating Sponsors:
Philips Healthcare
Conditions:
COPD
Eligibility:
All Genders
35-85 years
Brief Summary
Acute exacerbations of COPD contribute to significant morbidity and mortality in the United Kingdom (UK). The ability to assess response to treatment during exacerbations that require hospitalisation ...
Detailed Description
Introduction Patients admitted to hospital with acute exacerbations of COPD are at risk of significant in-hospital morbidity and mortality. Current markers of treatment success involve the integration...
Eligibility Criteria
Inclusion
- COPD (as defined by GOLD criteria
- Acute exacerbation of COPD necessitating hospital admission
- Expected to remain an inpatient for ≥ 24 hours
- Able to give informed consent to participation in the study
Exclusion
- Decompensated respiratory failure (pH \< 7.35)
- Significant physical, social or psychiatric factors that would prevent compliance with trial protocol
- Aged \< 35 years or aged \> 85 years
- Pregnancy
- BMI \> 30kg/m2
- Presence of another acute pathology (such as pulmonary embolism or pulmonary oedema) to explain the acute presentation
Key Trial Info
Start Date :
January 1 2016
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
June 1 2016
Estimated Enrollment :
11 Patients enrolled
Trial Details
Trial ID
NCT02721199
Start Date
January 1 2016
End Date
June 1 2016
Last Update
December 19 2016
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Guys and St Thomas NHS Trust
London, United Kingdom, SE1 7EH